Vinny Jindal | VP, Corporate Communications & Strategy |
Warren Huff | President & CEO |
Colin Meyer | EVP and Chief Research & Development Officer |
Manmeet S. Soni | EVP, COO, and CFO |
Yigal Nochomovitz | Citigroup |
Maury Raycroft | Jefferies, Inc. |
Annabel Samimy | Stifel Nicolaus |
Brian Skorney | Robert W. Baird |
Charles Duncan | Cantor Fitzgerald |
Joseph Schwartz | SVB Leerink |
Matt Kaplan | Ladenburg Thalmann |
Ladies and gentlemen, thank you for standing by and welcome to the Reata Pharmaceuticals Fourth Quarter Financial and Full Year 2020 Financial Results and Update on Development Programs Conference Call. An audio recording of today’s webcast will be available shortly after the call today on Reata’s website at reatapharma.com in the Investors section.
Before the company proceeds with its remarks please note that forward-looking statements disclosed in the company's press release. The company will be making forward-looking statements on today's call and there are many factors that could cause results to differ from expectations including those noted in the company's SEC filings. Today's statements are no guarantees of future outcomes.